Several possible studies
Story checked
Newer anticoagulants may help prevent strokes in AFib patients with previous brain bleeds (opens in a new tab)
medicalxpress.com · 2026-10-21
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Newer anticoagulants may help prevent strokes in AFib patients with previous brain bleeds
medicalxpress.com · 2026-10-21
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 8Not checkedFor people with atrial fibrillation and prior intracranial hemorrhage, anticoagulant use was associated with a lower risk of ischemic stroke and death, according to a new study published in Neurology.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 8Not checkedThe study also found no increased risk of more brain bleeds when people took newer anticoagulants.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 8Not checkedWarfarin, the older anticoagulant, was associated with a higher risk of future brain bleeds, while newer anticoagulants were not.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 8Not checkedThis was an observational study, so the findings do not show that anticoagulants caused the differences in risk, only that they were associated with them.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 5 of 8Not checkedThe study included 1,502 people with AFib and brain bleeds that occurred at least four months prior to their AFib diagnosis, and they were followed for up to two years.View evidenceHide evidence
As stated1,502 participants; up to two years follow-up
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 6 of 8Not checkedAfter adjustment, newer anticoagulant use was associated with an 83% lower risk of ischemic stroke and an 80% lower risk of death, without an increased risk of intracranial bleeding; warfarin was associated with a 51% lower risk of ischemic stroke, a 40% lower risk of death, and an 85% higher risk of brain bleeds.View evidenceHide evidence
As stated83% lower ischemic stroke risk; 80% lower death risk; 51% lower ischemic stroke risk with warfarin; 40% lower death risk with warfarin; 85% higher brain bleed risk with warfarin
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 7 of 8Not checkedThe article says the findings may help clinicians make more individualized treatment decisions, but more research is needed to identify who benefits most and who may still face a higher bleeding risk.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 8 of 8Not checkedA limitation noted in the article is that researchers excluded people who had a stroke or died within the first three months after an AFib diagnosis, so the results may not apply to that earlier period.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Europe PMC, Crossref · 15 candidate papers
Atrial fibrillation in stroke patients: facts, numbers and current challenges.
Neurological Research and Practice · 2026 · PubMed, Europe PMC
Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin
Blogging Stroke · 2014 · Crossref
Non-linear associations between blood pressure and clinical outcomes in atrial fibrillation: a systematic review and dose-response meta-analysis.
2026 · Europe PMC
Efficacy of anticoagulation therapy in elderly patients with clinically diagnosed Alzheimer's disease and atrial fibrillation: a clinical outcomes study.
Frontiers in Cellular Neuroscience · 2026 · PubMed
P4787Use of direct oral anticoagulants in patients with atrial fibrillation having a history of intracranial hemorrhage
European Heart Journal · 2019 · Crossref